Comparison of CpG s-ODNs,chromatin immune complexes,and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells

Abstract

Synthetic single-stranded oligodeoxynucleotides (15—30 bp) containing CpG motifs and phosphorothioate backbones (CpG s-ODN), immune complexes consisting of anti-nucleosome mAbs and mammalian chromatin (chromatin IC), and immune complexes consisting of anti-hapten mAbs and haptenated-double stranded DNA fragments (~600 bp) can all effectively stimulate transgenic B cells expressing a rheumatoid factor receptor by a TLR9-dependent process. However, differential sensitivity to both s-ODN and small molecule inhibitors suggests that stimulatory CpG sODN and chromatin IC may either access TLR9 via different routes or depend on discrete activation parameters. These data have important implications regarding the therapeutic application of TLR9 inhibitors to the treatment of systemic autoimmune diseases.

Keywords

Autoreactive B cells bafilomycin A chromatin immune complexes inhibitory s-ODN Toll-like receptor 9

References

Wolfowicz CB , Sakorafas P. , Rothstein TL , Marshak-Rothstein A. Oligoclonality of rheumatoid factors arising spontaneously in lpr/lpr mice . Clin Immunol Immunopathol 1988; 46: 382—395.

Jacobson BA , Sharon J. , Shan H. , Shlomchik M. , Weigert MG , Marshak-Rothstein A. An isotype switched and somatically mutated rheumatoid factor clone isolated from a MRL-lpr/lpr mouse exhibits limited intraclonal affinity maturation . J Immunol 1994; 152: 4489—4499.

Hannum LG , Ni D. , Haberman AM , Weigert MG , Shlomchik MJ A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease . J Exp Med 1996; 184: 1269—1278.

Wang H. , Shlomchik MJ Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J Exp Med 1999; 190: 639—649.

Rifkin IR , Leadbetter EA , Beaudette BC et al. Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells. J Immunol 2000; 165: 1626—1633.

Leadbetter EA , Rifkin IR , Hohlbaum AH , Beaudette B. , Shlomchik MJ , Marshak-Rothstein A. Immune complexes activate autoreactive B cells by co-engagement of sIgM and Toll-like receptors. Nature 2002; 419: 603—607.

Viglianti GA , Lau CM , Hanley TM , Miko BA , Shlomchik MJ , Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 2003; 19: 837—847.

Hemmi H. , Takeuchi O. , Kawai T. et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740—745.

Losman M. , Fasy TM , Novick KE , Monestier M. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp-+/+ mouse. J Immunol 1992; 148: 1561—1569.

10.

Yi A-K. , Tuetken R. , Redford T. , Waldschmidt M. , Kirsch J. , Krieg AM CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 1998; 160: 4755—4761.

11.

Krieg AM , Yi A-K. , Matson S. et al. CpG motifs in bacterial DNA trigger direct B-cell activation . Nature 1995; 374: 546—549.

12.

Stein CA , Subasinghe C. , Shinozuka K. , Cohen JS Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res 1998; 16: 3209—3221.

13.

Heil F. , Ahmad-Nejad P. , Hemmi H. et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8, and 9 subfamilies. Eur J Immunol 2003; 33: 2987—2997.

14.

Lee J. , Chuang T-H. , Redecke V. et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc Natl Acad Sci USA 2003; 100: 6646—6651.

15.

Lunec J. , Herbert K. , Blount S. , Griffiths HR , Emery P. 8-Hydroxydeoxyguanosine: a marker of oxidative DNA damage in systemic lupus erythematosus. FEBS Lett 1994; 348: 131—138.

16.

Garg DK , Ali R. Reactive oxygen species modified polyguanylic acid: immunogenicity and implications for systemic autoimmunity. J Autoimmun 1998 ; 11: 371—378.

17.

Krieg AM , Wu T. , Weeratna R. et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci USA 1998; 95: 12631—12636.

18.

Lenert P. , Stunz L. , Yi A-K. , Krieg AM , Ashman RF CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κB activation. Antisense Nucleic Acid Drug Dev 2001; 4: 247—256.

19.

Lenert P. , Rasmussen W. , Ashman RF , Ballas ZK Structural characterization of the inhibitory DNA motif for the type A (D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol 2003; 22: 621—631.

20.

Hacker H. , Mischak H. , Miethke T. et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 1998; 17: 6230—6240.

21.

Gursel I. , Gursel M. , Yamada H. , Ishii KJ , Takeshita F. , Klinman DM Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 2003; 171: 1393—1400.

22.

Latz E. , Schoenemeyer A. , Visintin A. et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190—198.

23.

Macfarlane DE , Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine and structurally related compounds. J Immunol 1998; 160: 1122—1131.

24.

Lund J. , Sato A. , Akira S. , Medzhitov R. , Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198: 513—520.

25.

Weber SM , Levitz SM Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism. J Immunol 2000; 165: 1534—1540.

26.

Yoshimori T. , Yamamoto A. , Moriyama Y. , Futai M. , Tashiro Y. Bafilomycin A1, a specific inhibitor of vacuolar-type H (+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem 1991; 266: 17707—17712.

27.

Bayer N. , Schober D. , Prchla E. , Murphy RF , Blaas D. , Fuchs R. Effects of bafilomycin A1 and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J Virol 1998; 72: 9645—9655.